SMX collapses on huge volume
SMX closed down 47.5% at $1.89, on volume of about 10.8 million shares against a 20-day average near 256,000. The Yahoo page notes the stock's recent news flow was mostly company-authored promotional material about its molecular marking and Digital Material Passport platform for gold, silver, plastics and luxury goods, and explicitly says the drop was not tied to a fresh earnings update. No cause is given for the move itself. The day's range was $1.70 to $5.61, market cap is listed at about $2.1 million, and the stock is down roughly 99% year to date.
Vicor down on no stated news
Vicor fell 12.9% to $191.50. The GuruFocus piece covering it is a valuation note rather than an explanation: it puts GF Value at $72.20, calls the stock 165.2% overvalued, flags a GF Score of 81/100 with valuation ranked 1/10 and growth 9/10, and notes $424.1 million of insider selling over twelve months with no buying. Current P/E is 61.5x against a five-year median of 74.0x. The article gives no reason for Friday's decline.
Nebius hit in the neocloud selloff
Nebius dropped 12.2%, closing at $165.47 on roughly 31 million shares, about 1.7 times its one-month average and its sixth decline in eight sessions after a 10% loss earlier in the week. CoreWeave fell nearly 12% the same day, so this is sector-wide rather than company-specific. Five separate items cover the name. The funding question is the thread running through them: second-quarter operating cash inflow was $2.246 billion while purchases of property, equipment and intangibles took $5.657 billion, a $3.411 billion gap, with quarter-end cash of $8.042 billion plus $1.056 billion restricted. A TradingView piece ties the selloff to scrutiny of the planned 600 MW Rotterdam data center and roughly $8.55 billion of debt, with revenue of $1.36 billion, net margin of 3.1% and return on equity of 0.4%. Price-to-sales is 34.12 against a historical median near 7.0 (the TradingView author cites 38.1x). Dan Ives, per TipRanks on October 15, argued the neocloud selloff is a buying opportunity because higher rates squeeze financing rather than demand. Against that, insiders have sold $318.2 million over twelve months with no buys, though director Arne Grimme bought 296 shares at $169.99 on October 16, taking him to 6,181 shares. Earnings are set for October 22.
Aurora Innovation drops ahead of earnings
Aurora fell 10.1% to $4.855 on 35.7 million shares versus a 29.2 million average. The Yahoo page says coverage has centred on the driverless truck scaling plan and a fresh valuation debate, with regulatory progress noted but investors focused on whether the roadmap converts into revenue and lower cash burn. It says the drop came alongside articles questioning whether too much future growth is already priced in. Earnings are October 28. Oppenheimer maintained Outperform on October 8 and raised its target from $15 to $16.
Codexis and Xometry
Codexis fell 8.8% to $1.24, on volume of 980,000 against a 1.14 million average, so a sizeable move on below-average turnover and no news attached. Xometry fell 8.7% to $90.91. The one piece of hard news is a Form 144 filed October 17. The accompanying GuruFocus note is valuation commentary: GF Value $48.11 versus the $90.91 price, GF Score 71/100 with growth at 10/10 and valuation 1/10, forward P/E of 70.5x, and net insider selling of $15.9 million over twelve months ($4.0 million bought, $20.0 million sold).
Rocket Lab's Neutron delay
Rocket Lab fell 8.0% to $50.84, its eighth straight down day after drops of 8% and 7%. The cause is specific: the Neutron rocket's debut has slipped from Q4 2026 into 2027 after inspections found voids, tiny air pockets between carbon fibre layers, in the forward dome of the first-stage propellant tank. The defect appeared after a switch to automated fibre placement following an earlier qualification failure on a manually built tank. Peter Beck said "possible success isn't our standard." Engineers have replicated and fixed the process issue, an aft dome passed through the revised process, and replacement dome manufacturing plus first-stage hydrostatic and cryogenic testing are expected in Q1 2027. No new launch date was given. Analysts cut: KeyBanc's Michael Leshock went to $100 from $135, keeping Overweight, citing one fewer revenue-generating Neutron launch in 2027 and lower multiples across high-growth space names. Citizens' Trevor Walsh kept Market Outperform but cut from $130 to $90. On the other side, ARK bought 168,633 shares worth about $9.3 million on Thursday as the stock fell. Backlog was $2.36 billion at end-June, up 137% year on year, Q2 free cash flow was negative $110 million, and insiders have sold $683.3 million over twelve months with no purchases.
TeraWulf and the AI-adjacent names
TeraWulf fell 7.4% to $11.68, down 24.1% over the month and inside a 52-week range of $10.35 to $29.84. The GuruFocus note gives GF Value at $5.94, a GF Score of 38/100 with growth at 0/10, a forward P/E of 174.6x against a 21.2x historical median, and net insider selling of $35.6 million. Cantor Fitzgerald kept Overweight but cut its target to $30, per a headline-only item. Nearby in the same complex: Datadog down 7.2%, Tower Semiconductor down 6.8%, Micron down 5.6% with headlines attributing it to a Nasdaq tech selloff, Credo down 4.9%, Oracle down 4.6% with several technical pieces and one headline on AI debt, Arista down 4.6% and Broadcom down 4.5%, with one headline noting AI chip stocks flashing a signal not seen since 2015. Context from the quote pages: Nasdaq closed down 2.14%, S&P 500 down 1.09%, VIX up 21.45% to 19.99.
Other movers and headline-only items
UiPath fell 6.3%, with a GuruFocus headline calling it undervalued on GF Value. Revolution Medicines fell 6.0% as William Blair initiated at Outperform. Planet Labs fell 6.7%, alongside a Form 4 and a report that director Kristen Robinson sold $565,560 of stock. Xometry, Beam Therapeutics (down 5.1%, CEO John Evans sold $1.19 million), Joby, Generac, Accenture, Kodiak Gas and Credo all carry Form 4 or Form 144 filings. On the long list of Netflix headlines (down 2.9%): Peter Rice, formerly of Disney, was named Chief Content Officer amid a leadership shakeup and layoffs, earnings land next week, and BMO, Wedbush and Rosenblatt all appear with target or rating updates. TSMC fell 2.3% after record Q3 results, with Barclays raising to $670 and DA Davidson holding at $500, and a CEO comment that overseas fab expansion will dilute gross margin by 3 to 4 percentage points in the latter part of the five-year period. Apple rose 0.4% on the heaviest headline volume in the list, centred on the foldable iPhone Duo selling out within minutes of pre-orders opening, with delivery slipping toward January 2027, plus a UBS Neutral reiteration at $296 citing shorter Pro wait times and limited upside, and a UK CMA proposal on tap-to-pay access.
Iran and the Strait of Hormuz
A Walter Bloomberg post relays Iran's foreign minister saying that if the US complies with Iran's conditions, the strait can be open within six days with talks resuming on the seventh. That is the whole of it, sourced to a Telegram channel. Related headlines in the list reference tankers hit near Hormuz. Crude is quoted up 2.61% at $99.02 on the Yahoo pages.
SMX collapses on huge volume with no stated cause
SMX (Security Matters) fell 47.5%, closing at $1.89 against a $3.60 prior close, on 10.3 million shares versus a 256,000-share average. The day's range was $1.70 to $5.61, so it traded above and well below the open before settling at the low end. Market cap is now about $2.1 million, and the stock is down roughly 99% year to date and 88% over the past month. Nothing in the Yahoo page explains the drop. Yahoo's own summary note says the recent coverage is mostly company-authored material about its molecular-marking and traceability platform for gold, silver, plastics and textiles, and that the selloff points to pressure "beyond the company's promotional messaging." In other words, no stated reason. Balance sheet figures shown: $33.5 million total cash, trailing net loss to common of $189.9 million, levered free cash flow of -$30.9 million, 25 employees.
Nebius down 12% on AI funding fears
Nebius was the big liquid casualty, down 12.2%, and five separate items cover it. GuruFocus puts the close at $165.47, a loss of $22.94 on about 31 million shares, 1.7 times the one-month average, and the sixth decline in eight sessions after a 10% drop earlier in the week. The driver given is a sector-wide selloff in neocloud names, with CoreWeave off nearly 12% the same day. A second GuruFocus piece frames the funding math directly: second-quarter operating cash inflow was $2.246 billion against $5.657 billion of property, equipment and intangible purchases, a $3.411 billion gap, with quarter-end cash of $8.042 billion plus $1.056 billion restricted. That piece notes Dan Ives had argued on October 15 that the neocloud selloff was a buying opportunity because higher rates squeeze financing rather than demand. A TradingView note by KalaGhazi adds the specifics behind the worry: roughly $8.55 billion of debt financing capacity, a planned 600 MW Rotterdam data center, $1.36 billion of revenue mostly from Nebius AI Cloud, net margin of 3.1% and return on equity of 0.4%, against a 38.1x price-to-sales multiple. GuruFocus has P/S at 34.12 versus a historical median near 7.0, a GF Score of 52/100 with momentum 10/10 and valuation 2/10, and an Altman Z-score of 2.33. Insiders have sold $318.2 million over twelve months with no buys, against which director Arne Grimme's Form 4 purchase of 296 shares at $169.99 (taking him to 6,181 shares) is the lone offsetting item, reported separately twice. Earnings are scheduled for October 22.
Vicor falls 12.9%
Vicor dropped 12.9% to $191.50, inside a 52-week range of $57.00 to $382.65. The GuruFocus piece gives no operating news behind the move; it is a valuation note. GF Value is $72.20, which it calls 165.2% overvaluation, with a GF Score of 81/100 that breaks down as growth 9/10, momentum 9/10, financial strength and profitability 8/10 each, and valuation 1/10. Trailing P/E is 61.5x against a five-year median of 74.0x, forward P/E 31.3x. Insiders sold $424.1 million over the past twelve months with no purchases, and of seven gurus holding, two added and six trimmed.
Aurora Innovation off 10% ahead of earnings
Aurora fell 10.1% to $4.855 on 35.7 million shares against a 29.2 million average, a move of about 1.5 times its own 20-day ATR. The Yahoo page offers no single cause and points to the general mix of driverless truck scaling plans against cash burn and an unclear path to profitability, citing a new five-year US waiver for self-driving trucks and a management target of 30,000 trucks and $5 billion revenue by 2030. Q2 showed $2 million revenue against a $270 million loss, trailing free cash flow of -$414 million, and $1.22 billion cash. Earnings are due October 28. Oppenheimer maintained Outperform on October 8 and raised its target to $16 from $15.
Rocket Lab's eighth straight decline on the Neutron delay
Rocket Lab fell 8.0% to $50.84, the eighth consecutive down day after drops of 8% and 7%, and six items cover the same event. The first Neutron launch has slipped from Q4 2026 into 2027 after inspections found voids, tiny air pockets between carbon fibre layers, in the forward dome of the first-stage propellant tank. CEO Peter Beck said "possible success isn't our standard." The defect surfaced after the company moved to automated fibre placement following an earlier qualification failure on a manually built tank; engineers have reproduced the defect and changed the process, and an aft dome passed through the revised process. Replacement dome manufacturing and inspection are expected to finish before Q1 2027, with first-stage assembly and hydrostatic and cryogenic testing during that quarter. No new launch date was given. Two brokers cut targets while keeping positive ratings: KeyBanc's Michael Leshock to $100 from $135, citing one fewer revenue-generating Neutron launch in 2027 plus lower multiples across high-growth space names, and Citizens' Trevor Walsh to $90 from $130, keeping Market Outperform. On the other side, ARK bought 168,633 shares worth about $9.3 million on Thursday; that article also notes Q2 free cash flow of -$110 million, a June-end backlog of $2.36 billion, up 137% year on year, and an agreement covering 20 Electron launches. GuruFocus has GF Value at $39.19, a GF Score of 77/100 with growth 10/10 and profitability 3/10, P/S of 38.78 against a median of 18.88, EPS of -$0.28, and $683.3 million of insider selling over twelve months with no buys. A TradingView post by trader315269 reads the pullback as a technical entry into a 61.8–78.6% Fibonacci zone; it is a retail chart view, not research.
Codexis down 8.8% on light volume
Codexis fell 8.8% to $1.24 on 980,000 shares, below its 1.14 million average, which is worth noting because the move was large relative to its own volatility but not volume-driven. The Yahoo page gives no cause. It is down 51% over six months and 53% over a year. Q2 revenue was $14.91 million with a $12.01 million loss, cash of $54.9 million, debt-to-equity 220%. Earnings November 5. Piper Sandler kept Overweight on August 17 but cut its target to $8 from $9.
Xometry down 8.7% alongside a Form 144
Xometry fell 8.7% to $90.91, with a Form 144 filed October 17 noted separately. The GuruFocus piece is valuation-only and gives no operational reason: GF Value $48.11 against the $90.91 price, forward P/E 70.5x versus a five-year median near 3.8x, GF Score 71/100 with growth 10/10, momentum 9/10, profitability 3/10 and valuation 1/10. Insiders bought $4.0 million and sold $20.0 million over twelve months, a net $15.9 million of selling. The 52-week range is $35.86 to $112.94.
Iran, the Strait and oil
Iran's foreign minister said via Telegram that if the US complies with Iran's conditions, the Strait can open within six days with talks resuming on the seventh. That is the whole of the statement. For context from the quote boards in the same material, WTI was around $99 and Brent near $110. The item is tagged to CAN, which was down 8.2%; nothing in the material connects the two.
AI infrastructure and semis under broad pressure
A cluster of names moved down together with the Nasdaq off 2.14% and the VIX up 21% to 19.99. TeraWulf fell 7.4%, with Cantor Fitzgerald keeping Overweight and cutting its target to $30 per the headline. Datadog fell 7.2%, Tower Semiconductor 6.8%, SanDisk 6.8%, Micron 5.6%, Astera Labs 5.4% with Stifel reiterating at a $460 target, Credo 4.9%, Oracle 4.6%, Arista 4.6% and Broadcom 4.5%. These are headline-only, so no detail beyond the names and directions, but they line up with the same AI-financing anxiety that the Nebius and Rocket Lab full-text pieces describe. One related headline states Anthropic secured a BB+ rating from KBRA ahead of a $35 billion chip financing deal, with banks assembling a further $60 billion. Another says Microsoft pulled out of a UK data centre deal with Nscale, per the Telegraph.
Netflix ahead of earnings
Netflix fell 2.9% and carries the heaviest headline count on the list. The substance across those headlines: Peter Rice, formerly of Disney, has been named Chief Content Officer in a leadership shake-up accompanied by layoffs, and earnings are due next week alongside Tesla and Meta. Three brokers appear in headlines with targets lowered or held: BMO Capital to $125, Wedbush to $90, and Rosenblatt holding $75 at Neutral. These are headline-only, so the reasoning behind each is not available here.
Smaller moves and routine filings
TSMC fell 2.3% despite record Q3 results per one headline, with Barclays raising to $670 and DA Davidson holding $500; a separate headline covers a planned $4 billion Taiwan-backed AI hub in Texas, and a TSMC CEO quote says overseas fab expansion will dilute gross margin by 3 to 4 percentage points in the latter part of the five-year period. Planet Labs fell 6.7% with director Kristen Robinson selling $565,560 of stock. UiPath fell 6.3%. Revolution Medicines fell 6.0% as William Blair initiated at Outperform. Beam Therapeutics fell 5.1% with CEO John Evans selling $1.19 million. SpaceX was down 1.7% amid a long run of Starlink and Tesla-merger headlines, including Barclays calling a Tesla-SpaceX merger feasible but uncertain on timing and approval. Apple was up 0.4%, with headlines on the iPhone Duo foldable selling out at pre-order and delivery slipping into November, UBS reiterating Neutral at $296 on softer iPhone wait-time data, and a UK CMA proposal on tap-to-pay access. The rest of the list is Form 4 and Form 144 filings and chart posts with no substance behind them.
SMX collapses 47.5%
SMX was down 47.5%, closing at $1.89 after a day's range of $1.70 to $5.61 on volume of 10.3 million shares against a 20-day average of about 256,000. The Yahoo Finance page gives no stated reason for the drop. What it does show is a market cap of just $2.06 million, a 52-week range running from $1.70 up to $5,496, down roughly 99% year to date, with $33.5M total cash and levered free cash flow of -$30.9M. The company's own recent messaging has been about its molecular-marking and traceability platform for gold, silver, plastics and textiles. Shares ticked up 5.3% after hours.
Vicor down 12.9%
Vicor fell 12.9% to $191.50, inside a 52-week range of $57.00 to $382.65. The GuruFocus note attaches no company news to the move; it is a valuation piece, putting GF Value at $72.20 (so 165% above fair value on their method), a GF Score of 81/100 with growth 9/10 but valuation 1/10, a trailing P/E of 61.5x against a five-year median of 74.0x, forward P/E 31.3x, and insider sales of $424.1M over twelve months with no buying.
Nebius hit hardest of the AI infrastructure names
Nebius was down 12.2%, closing at $165.47 on roughly 31 million shares, about 1.7 times its one-month average and its sixth decline in eight sessions after a 10% loss earlier in the week. GuruFocus ties it to broad weakness in the neocloud group, with CoreWeave off nearly 12% the same day. The funding question is the thread running through all four Nebius pieces: Q2 operating cash inflow of $2.246 billion against $5.657 billion of property, equipment and intangibles purchases, a $3.411 billion gap, with $8.042 billion cash plus $1.056 billion restricted at quarter end. The TradingView piece frames the same issue around roughly $8.55 billion of debt and the planned 600 MW Rotterdam data center, noting revenue of $1.36 billion, net margin 3.1%, return on equity 0.4%, and a price-to-sales of 38.1x (GuruFocus puts P/S at 34.12 versus a historical median near 7.0). Dan Ives, via TipRanks on October 15, argued the selloff was a buying opportunity on the grounds that higher rates squeeze financing rather than demand. Against that, insiders have sold $318.2M over twelve months with 33 sells to one buy; the one buy was director Arne Grimme picking up 296 shares on October 16 at $169.99, taking him to 6,181 shares. Earnings are scheduled for October 22.
Aurora Innovation off 10.1%
Aurora fell 10.1% to $4.855 on 35.7 million shares against a 29.2 million average. Yahoo's page flags a five-year US waiver that removed one deployment hurdle for driverless trucks, while pointing to continued cash burn, losses, and a valuation some analysts call stretched. Q2 FY26 revenue was $2M against a $270M loss, trailing cash $1.22B, levered free cash flow -$414M. The average one-year target shown is $12.13, and Oppenheimer on October 8 kept Outperform while raising its target from $15 to $16. Earnings October 28.
Codexis and Xometry
Codexis was down 8.8% to $1.24, with no news attached on the Yahoo page beyond the price data: 52-week range $0.96 to $2.98, Q2 FY26 revenue $14.91M and a $12.01M loss, cash $54.9M, debt/equity 220%. Earnings November 5. Xometry fell 8.7% to $90.91, with a Form 144 filed the same day. The GuruFocus piece on it is valuation only, no operating news: GF Value $48.11 against the $90.91 price, GF Score 71/100 with growth 10/10 and valuation 1/10, forward P/E 70.5x, and net insider selling of $15.9M over twelve months ($4.0M bought, $20.0M sold).
Rocket Lab's Neutron delay, eighth straight down day
Rocket Lab was down 8.0% to $50.84, its eighth consecutive decline after drops of 8% and 7% earlier in the week. The cause is specific: inspections found voids, tiny air pockets between carbon fibre layers, in the forward dome of Neutron's first-stage propellant tank, pushing the debut launch from Q4 2026 into 2027. Peter Beck said "possible success isn't our standard." The defect appeared after a switch to automated fibre placement following an earlier manual-tank qualification failure; engineers have replicated it and changed the process, and an aft dome came through the revised process better. Replacement dome manufacturing and inspection is expected to finish before Q1 2027, with first-stage assembly and hydrostatic and cryogenic testing in that quarter. No new launch date. KeyBanc's Michael Leshock cut his target to $100 from $135 keeping Overweight, modelling one fewer revenue-generating Neutron launch in 2027 and citing lower multiples across high-growth space names; Citizens' Trevor Walsh kept Market Outperform but cut to $90 from $130. ARK bought 168,633 shares, about $9.3 million, on Thursday. Backlog was $2.36 billion at end-June, up 137% year on year, with Q2 free cash flow of -$110 million. Insiders have sold $683.3M over twelve months with no purchases.
TeraWulf
TeraWulf fell 7.4% to $11.68, down 24.1% over the month and 15.7% over the year, in a 52-week range of $10.35 to $29.84. The GuruFocus piece supplies no event behind the drop, only metrics: GF Value $5.94 against the price, GF Score 38/100 with growth 0/10 and financial strength 2/10, forward P/E 174.6x, and net insider selling of $35.6M. Separately, Cantor Fitzgerald kept Overweight and lowered its target to $30, headline only.
The semis and AI-complex backdrop
The common driver behind several of these is visible in the index data on the pages themselves: Nasdaq closed down 2.14%, S&P 500 down 1.09%, VIX up 21.45% to 19.99, with the 10-year at 5.10%. Headline-only items in your list point the same way, including one from Investing.com that the SOX chip index posted its longest losing streak since 2008 as AI worries deepened, and an item noting Anthropic received a BB+ rating from KBRA ahead of a $35 billion chip financing, with banks assembling a further $60 billion. Among your chip and AI names, Micron was down 5.6%, Astera Labs 5.4%, Credo 4.9%, Oracle 4.6%, Arista 4.6%, Broadcom 4.5%, TSMC 2.3%, with Tower Semiconductor off 6.8%. Datadog fell 7.2%. All of these are headline-only, so I can't tell you more than that the moves happened alongside the sector selloff.
Netflix cluster ahead of earnings
Netflix was down 2.9% on a heavy run of headline-only items: Peter Rice, formerly of Disney, named chief content officer, alongside reports of layoffs and a leadership shakeup, with an October 26 handover mentioned. BMO cut its target to $125, Wedbush to $90, Rosenblatt held at $75 with a Neutral rating. Earnings land next week alongside Tesla, Meta, IBM and others.
Smaller decliners and quieter names
UiPath was down 6.3%, Revolution Medicines 6.0% with William Blair initiating at Outperform, Planet Labs 6.7% with director Kristen Robinson selling $565,560 of stock, Beam Therapeutics 5.1% with CEO John Evans selling $1.19M, NioCorp 4.1% on two 8-K filings covering results and a material agreement, Sezzle 3.6%, Modine 3.3%, Generac 2.9%, Mercury Systems 2.8%, Amphenol 2.6%. All headline-only. Apple was the main gainer at up 0.4%, with pre-orders for the foldable iPhone Duo selling out within minutes and delivery dates slipping into January 2027, while UBS kept Neutral at $296 citing iPhone Pro wait times of four days versus longer in prior cycles. Accenture up 2.1%, Aflac 1.6%, Costco 1.1%, Paychex 0.8%. SpaceX fell 1.7% amid a thick but entirely headline-level stream on Starlink in Ukraine, spectrum, and Tesla merger speculation, including Barclays calling a merger feasible with uncertain timing, and Evercore raising its target to $275. Nothing in the rest of the list carries enough behind it to need your attention today.
SMX collapses to $1.89
SMX was the day's extreme, down 47.5% to $1.89 on volume of 10.3 million shares against a 256,000-share 20-day average, roughly 40 times normal. The Yahoo page shows a day's range of $1.70 to $5.61 against a previous close of $3.60, a 52-week range running from $1.70 all the way up to $5,496 (reverse-split distortion), and a market cap now at $2.06 million. It is down 88% over a month and 98.97% year to date. The page gives no reason for the move; the only recent coverage it notes is company-authored material on its Digital Material Passport and molecular-marking work in gold, silver, plastics and luxury goods. Shares were $1.99, up 5.29%, after hours. Note the item headline here says +16.4%, which contradicts the quote and the article itself.
Vicor down 12.9%
Vicor fell 12.9% to $191.50. GuruFocus gives no news catalyst, just its valuation read: GF Value of $72.20 against the current price, which it calls 165% overvalued, a GF Score of 81/100 with growth at 9/10 and valuation at 1/10, trailing P/E of 61.5x versus a five-year median of 74x, and forward P/E of 31.3x. It also flags $424.1 million of insider selling over twelve months with no buying, and seven gurus holding with two adding and six trimming. The 52-week range is $57.00 to $382.65.
Nebius down 12.2%, funding model under scrutiny
Nebius fell 11.99% to $165.47, losing $22.94 on about 31 million shares, roughly 1.7 times the one-month average, its sixth decline in eight sessions and following a 10% drop earlier in the week. GuruFocus ties it to a broad neocloud selloff, noting CoreWeave fell nearly 12% in the same session. The substance behind the worry is cash: second-quarter operating cash inflow was $2.246 billion while purchases of property, equipment and intangibles took $5.657 billion, a $3.411 billion gap, against quarter-end cash of $8.042 billion plus $1.056 billion restricted. A TradingView piece frames the same issue around the planned 600 MW Rotterdam data center and roughly $8.55 billion of debt, with revenue of $1.36 billion, net margin of 3.1% and return on equity of 0.4%, and asks whether higher financing costs break the economics of debt-funded buildout. Valuation is stretched on P/S at 34.12 versus a historical median near 7.0 (the TradingView piece cites 38.1x), EPS is negative at -$0.13, and GF Score is 52/100 with momentum 10/10 and valuation 2/10. Against that, Dan Ives was reported by TipRanks on October 15 calling the neocloud selloff a buying opportunity on the argument that rates squeeze financing, not demand. Insiders sold $318.2 million over twelve months with no buys, though director Arne Grimme filed a Form 4 for a purchase of 296 shares at $169.99, taking him to 6,181 shares, the single insider buy against 33 sells in a year. Earnings are scheduled for October 22.
Aurora down 10.1% into October 28 earnings
Aurora Innovation fell 10.09% to $4.855 on 35.7 million shares against a 29.2 million average, which puts it down 16.7% on the week and 23.7% over a month, though still up 26.4% year to date. The Yahoo page offers no specific catalyst, describing the company as a scale-up story targeting more than 30,000 driverless trucks and about $5 billion of revenue by 2030 while still burning cash. Q2 FY26 revenue was $2 million against a $270 million loss, cash is $1.22 billion, levered free cash flow is -$414 million. Earnings are October 28. The average one-year target shown is $12.13; Oppenheimer maintained Outperform on October 8 and raised its target from $15 to $16.
Rocket Lab down 8% on Neutron slipping to 2027
Rocket Lab fell nearly 8% to $50.84, an eighth straight down day after drops of 8% and 7%, and is down about 13% on the week. The cause is specific: inspections found voids, tiny air pockets between carbon-fiber layers, in the forward dome of Neutron's first-stage propellant tank, produced via an automated fiber-placement process adopted after an earlier qualification failure on a manually built tank. Peter Beck said "possible success isn't our standard" and chose to redesign rather than fly. Engineers have replicated the defect and changed the process, and an aft dome passed with better results. Replacement dome manufacture and inspection should finish before Q1 2027, with first-stage assembly and hydrostatic and cryogenic testing in that quarter; no new launch date was given. Analysts cut targets but held ratings: KeyBanc's Michael Leshock to $100 from $135, stripping out one revenue-generating 2027 Neutron launch and citing lower multiples across high-growth space names, and Citizens' Trevor Walsh to $90 from $130 at Market Outperform. Cathie Wood's ARK bought 168,633 shares worth about $9.3 million on Thursday as the stock fell nearly 7%. Offsetting the delay, backlog was $2.36 billion at the end of June, up 137% year on year, plus an agreement covering 20 Electron launches; Q2 free cash flow was -$110 million. GuruFocus puts GF Value at $39.19, GF Score at 77/100 with growth 10/10 and profitability 3/10, P/S at 38.78 versus an 18.88 median, and insider selling at $683.3 million over twelve months with no buys. A TradingView post argues the pullback has reached the 61.8%–78.6% Fibonacci zone on long-term trendline support with oversold momentum.
Codexis and Xometry
Codexis fell 8.82% to $1.24 on below-average volume, 980,000 shares against a 1.14 million average, with no catalyst on the page. It is down 51% over six months and 53% over a year, with a 52-week low of $0.96. Q2 FY26 revenue was $14.91 million on a $12.01 million loss, cash $54.9 million, debt-to-equity 220%. Earnings are November 5; Piper Sandler kept Overweight on August 17 while cutting its target from $9 to $8. Xometry fell 8.7% to $90.91, again with no news attached, only GuruFocus's valuation note: GF Value $48.11 against the price, GF Score 71/100 with growth 10/10 and valuation 1/10, forward P/E of 70.5x, and net insider selling of $15.9 million over twelve months ($4.0 million bought, $20.0 million sold).
TeraWulf down 7.4%
TeraWulf closed down 7.5% at $11.68, off 24.1% over a month and 15.7% over a year, against a 52-week range of $10.35 to $29.84. No news driver is given; GuruFocus has GF Value at $5.94, GF Score at 38/100 with growth 0/10 and financial strength 2/10, a forward P/E of 174.6x, and net insider selling of $35.6 million. Separately, and headline-only, Cantor Fitzgerald kept Overweight while lowering its target to $30.
The AI and semi complex, headline-only
The common thread under most of the rest is the same risk-off tape the Nebius and Rocket Lab pieces describe. The Nasdaq closed down 2.14% at 26,140, the S&P 500 down 1.09%, and VIX up 21.45% to 19.99, with a headline on the Investing.com page noting the SOX chip index posted its longest losing streak since 2008 on AI worries. On the watchlist: Datadog down 7.2%, Tower Semiconductor down 6.8%, UiPath down 6.3%, Micron down 5.6% with a GuruFocus headline attributing it to the Nasdaq tech selloff, Astera Labs down 5.4% with Stifel reiterating a $460 target, Credo down 4.9%, Oracle down 4.6%, Arista down 4.6%, and Broadcom down 4.5%, with one headline flagging a signal in AI chip stocks not seen since 2015 and another noting Anthropic received a BB+ rating from KBRA ahead of a $35 billion chip financing deal, with roughly $60 billion more being assembled. TSMC fell 2.3% despite record Q3 results, a Barclays target raise to $670, and headlines on a planned $4 billion Taiwanese AI hub in Texas serving Nvidia's supply chain. These are all headline-only, so the moves are what I can state, not the reasoning behind each.
Netflix, Apple, SpaceX
Netflix fell 2.9% on a leadership story: Peter Rice, formerly of Disney, was named Chief Content Officer, alongside reported layoffs. Rosenblatt held Neutral at $75, BMO lowered to $125 and Wedbush to $90. Netflix reports next week alongside Tesla, Meta and others. Apple was one of the few green names, up 0.4%, with headlines on the iPhone Duo foldable selling out within minutes of pre-orders opening and delivery slipping toward January 2027, UBS reiterating Neutral at $296 on softer Pro wait times, and the UK CMA proposing changes to tap-to-pay access. SpaceX fell 1.7% despite Evercore raising its target to $275, with a cluster of items on Tesla merger speculation (Barclays calling it feasible but uncertain on timing, prediction markets at 77% odds by 2028) and the Starlink Ukraine access question. All headline-only.
Everything else quiet
The remainder of the list is routine, mostly Form 4 filings and small moves: Planet Labs down 6.7% with director Kristen Robinson selling $565,560 of stock, Revolution Medicines down 6.0% with William Blair initiating at Outperform, Beam down 5.1% with CEO John Evans selling $1.19 million, plus sub-4% moves in NioCorp, Sezzle, SoundHound, Modine, Netflix peers and the usual ETF flow notes. Nothing there needs a closer look on its own.
SMX collapses with no stated reason
SMX (Security Matters) is down 48.6%, the worst move on the list by a wide margin. The alert line that generated the item described a 16.4% gain on volume 6.5 times the 20-day average, but the Yahoo quote page behind it shows the stock closing at $1.89, down $1.71 or 47.5%, with a day's range of $1.70 to $5.61 and volume of 10.1 million against an average of 93,576. That is the whole of the material, a quote page, with no news attached explaining the move. Context from the same page: market cap is $2.06m, the stock is down 88% over one month and roughly 99% year to date, the 52-week range runs from $1.70 to $5,496, and the company carries $33.5m cash against levered free cash flow of -$30.9m. If you hold this, the page itself offers no cause.
Nebius down 12.2% on funding-gap worries
Nebius fell 12.2%. GuruFocus framed it as a cash question rather than a demand question: in the second quarter Nebius generated $2.246bn of operating cash inflow while spending $5.657bn on property, equipment and intangibles, a $3.411bn gap. Quarter-end cash and equivalents were $8.042bn with a further $1.056bn restricted. The piece noted Dan Ives had argued on October 15 via TipRanks that the neocloud selloff was a buying opportunity because higher rates squeeze financing rather than underlying demand, and the article's point was that the buildout still has to be paid for. GuruFocus puts its GF Score at 52/100 with momentum well ahead of the other categories. Separately, a Form 144 filing for Nebius Group dated 15 October appeared, headline only with no detail in the item.
Codexis off 9.2%, no news behind it
Codexis is down 9.2%, trading around $1.245 intraday on volume of 975k against a 1.14m average, so a large move on unremarkable volume. The item is a quote page with no accompanying story, so there's no stated cause. For reference from that page: Q2 FY26 revenue of $14.91m and a $12.01m loss, $54.92m cash, next earnings November 5, and Piper Sandler maintaining Overweight back on 17 August while cutting its target from $9 to $8.
AST SpaceMobile down 8.6% after a day-earlier gain
ASTS fell 8.6% today. The article covering it is dated the prior session and describes a 5.5% rise to $44.46 on October 15, so it doesn't address today's drop. What it does give: a 52-week range of $39.87 to $133.86, a GF Score of 44/100 with profitability at 1/10 and growth 0/10, and insider activity of $0.8m bought against $451.6m sold over the past twelve months, a net $450.8m of selling. GuruFocus's own GF Value of $582.48 against the $44.46 price is flagged in the article as unreliable for a loss-making, cash-flow-negative company.
Rocket Lab down 8.0% on the Neutron delay
This is the most heavily covered name in the list, with eight separate items, and they all trace to one event. On October 14 CEO Peter Beck said the first Neutron launch slips into 2027 from Q4 2026. The cause is manufacturing defects in the forward dome of the first stage's carbon-composite propellant tank: inspections found small air pockets, or voids, between carbon fibre layers, traced to a recent design change that thickened parts of the tank for strength and made those sections harder to cure without trapping air. Beck said the voids would not necessarily cause a failure but the tank missed the company's safety margins, hence "Possible success isn't our standard." Rocket Lab says the manufacturing process has been fixed and validated on a second tank section, with replacement dome manufacture and inspection finishing before Q1 2027 and first-stage assembly plus hydrostatic and cryogenic testing during that quarter. Needham's read is a minimum four-month delay, with key tests possibly as early as January and no launch before Q2 2027.
The analyst response to Rocket Lab splits on targets, not ratings
Every firm covered kept its rating and only moved numbers. Citizens' Trevor Walsh held Market Outperform and cut to $90 from $130. KeyBanc's Michael Leshock held Overweight and cut to $100 from $135, citing one fewer revenue-generating Neutron launch in 2027 plus lower multiples across high-growth space stocks. Needham kept Buy and $120 while trimming its FY2027 revenue estimate. Stifel reiterated Buy at $132 and Cantor Fitzgerald Overweight at $122. Against that, ARK Invest bought 168,633 shares worth about $9.3m on Thursday as the stock fell nearly 7%. Other figures across the pieces: the stock is down roughly 19% on the week and about 21% year to date, versus the S&P Aerospace & Defense ETF down about 7.6% and the Russell 3000 up about 12%; backlog was $2.36bn at end-June, up 137% year on year, with an agreement covering 20 Electron launches; Q2 free cash flow was negative $110m; insiders sold about $26.96m over three months and $683.3m over twelve, with no buying. GuruFocus scores it 77/100 and calls it roughly 41% overvalued against a GF Value near $39 at a $55.25 price. One further headline-only item, "Company News for Oct 16, 2026" from Nasdaq, is tagged to RKLB with no detail given.
TeraWulf down 7.4% as Cantor trims target
WULF fell 7.4%. Cantor Fitzgerald kept its Overweight rating on October 12 but cut the target to $30 from $37. GuruFocus is considerably more negative on the name than the rating implies: GF Score of 38/100, financial strength 2/10, profitability 2/10, valuation 1/10, momentum 7/10, and a GF Value of $5.94 against a $12.62 price. Insiders bought $189,949 and sold $5,321,200 over the last three months. Market cap about $6.3bn.
Butterfly Network and other filing-only items
Butterfly Network is down 7.8%, and the only item attached is a Form 4 for director Michael Noonen dated 13 October, with no transaction detail in the material. Nothing in the list explains the move. Planet Labs is down 6.7% with a Form 144 filing headline and an unrelated Truth Social post about a Texas Senate race; UiPath is down 6.3% with a Form 144 and a chart alert noting the move came on half the usual volume. None of these carry an explanation.
The broad AI and semis selldown
Several of your names moved together with the tape rather than on their own news. The Nasdaq closed down 2.14% and the VIX rose 23.7% to 20.38, with Investing.com's front page running headlines on the Nasdaq's worst week in over 18 months, Barclays' Cau saying the best of the AI trade may be over, and BofA advising a risk-off stance on higher real yields. Within that, Datadog fell 7.2%, Coherent 7.1%, Micron 5.6%, Astera Labs 5.4%, NetApp 5.1%, Arista 4.6%, Oracle 4.6%, Broadcom 4.5% and TSMC 2.3%. The Micron items are headline-only and mostly routine: an "ETFs are net sellers" note, a cluster of Form 4s dated 13 October covering essentially the whole board and executive team, and a report that SVP and Chief Legal Officer Michael Ray sold $5.8m of stock. Investing.com ran a "Why is Micron stock sliding today?" piece, headline only, so I can't tell you what it says. Oracle has headline-only items on moderately bearish options sentiment and $66.8m of net ETF buying on October 14, and Broadcom items on $121.5m of net ETF buying plus a note that Anthropic received a BB+ rating from KBRA ahead of a $35bn chip financing deal with another $60bn reportedly being assembled. TSMC headlines reference a raised $670 target from an unnamed firm, DA Davidson holding at $500, Q3 earnings call highlights, and a planned $4bn Taiwanese AI hub in Texas tied to Nvidia's supply chain.
Netflix down 2.9% on a content-chief change
Netflix is the busiest headline-only cluster. Peter Rice, formerly of Disney, was named Chief Content Officer, with Bela Bajaria departing, and multiple outlets tie the share dip to that announcement alongside a workforce reduction. BMO cut its target to $125 citing engagement concerns, Wedbush cut to $90, and Rosenblatt held at $75 with a Neutral rating. Earnings are flagged as upcoming in IBD's calendar pieces. These are all headlines, so I don't have the reasoning behind the target cuts beyond BMO's stated engagement concern.
SpaceX down 1.7% amid heavy but mostly headline-level flow
SPCX fell 1.7% on a long run of headlines: prediction markets putting Tesla-SpaceX merger odds at 77% by 2028, Barclays calling a merger feasible with timing and approval uncertain, Evercore ISI raising its target to $275 on compute growth, Tesla unveiling a Roadster using SpaceX thrusters, and a Reuters-sourced report that the White House ordered SpaceX to limit Ukraine satellite service, with Trump saying neither he nor Musk was responsible and Zelenskiy saying there is no discussion of substituting Starlink. European satellite names including Eutelsat rallied on those Starlink headlines. Earnings are due.
Biotech and the smaller names
Revolution Medicines fell 5.9% with William Blair initiating at Outperform, Beam fell 5.0% with only a Form 144 attached, and CRISPR fell 4.3% with two Form 4s and a UBS initiation at Neutral with a $52 target. All headline-only, so no reasoning available on any of them.
Apple the exception on the upside
Apple rose 0.4%, one of the few green names and covered as a defensive hold with AI stocks under pressure. The foldable iPhone Duo, at $1,999, sold out within minutes of preorders opening, with delivery slipping from October 23 to November 16-23, though one item notes the fast sellout may reflect limited initial inventory. UBS reiterated Neutral with a $296 target, pointing to Evidence Lab data across 30-plus markets showing iPhone Pro wait times four days shorter than last year. The UK CMA has proposed changes to Apple's tap-to-pay access, which Apple is preparing to contest. There's also a thick layer of routine ETF flow items, including $365.1m of net ETF buying on October 14, and a Form 4 showing SVP Jennifer Newstead sold 2,399 shares for $827,655.
Quiet remainder
The rest of the list is routine. Aflac up 1.6% and AngloGold up 1.4% with only a Japan Post Form 4 and a GF Score piece behind them, Costco up 1.1% on ETF-flow and options-activity headlines, and small declines in SNX, KGS, ONON, CMP, LU, RGNX, TTWO and INCY tied to filings, routine analyst reiterations or fund-flow notes. Nothing there needs a second look today.
Datavault AI jumps on two 8-K filings
Datavault AI is up 12.3%, the largest move on the list. Two 8-K filings landed the same day: one covering officer and director changes plus compensatory arrangements and a Regulation FD disclosure, the other reporting entry into a material definitive agreement. Both are headline-only here, so the substance of the agreement and who is coming or going isn't visible from what I have. The third DVLT item is a TradingView chart post from a retail author calling for a move above $0.40 to $1.00 off a wave pattern, not company news.
Vicor and the AI infrastructure financing selloff
Vicor is down 10.4%, and GuruFocus ties the drop to worries about the cost of financing AI infrastructure buildout. Recent government reports showed hotter-than-expected consumer and wholesale inflation, raising fears that rates stay high enough to squeeze capital-intensive data centre projects. Vicor makes modular power components for data centres, telecoms, aerospace and EVs, with a $10.08bn market cap. GuruFocus puts the stock at $218.67 against a GF Value of $72.10, a 203% premium, a trailing P/E of 70.2x versus a five-year median of 74.21x, and a GF Score of 81 with valuation scored 1 out of 10. Insiders sold $424.1m over the past year with no buying, and six of seven tracked gurus trimmed. The same article names Vertiv and nVent as falling alongside it, and Vertiv does appear separately on your list down 3.6%, with Mizuho cutting its target to $280 and GuruFocus flagging a GF Value of $179.56 against a $214.75 price. Arista is down 5.0% and Coherent 4.8%, both headline-only, and the TSMC and Micron items include a GuruFocus piece headlined on chip stocks falling on inflation concerns and an Investor's Business Daily headline on chips tumbling on AI investment worries. That's the connective thread running through much of today's red.
TeraWulf up on the AI data centre story
TeraWulf is up 9.4%. The only item is a TradingView long write-up, not company news, but it lays out the contracted position: a 20-year Anthropic lease for roughly 401 MW at the Justified Data Campus worth about $19bn over the initial term, multiple Fluidstack deals backstopped by Google credit and warrants, total contracted revenue above $27bn across roughly 839 MW, and projected run-rate rent near $1.76bn at full delivery. Muskie contracted power doubled to 1 GW with the second 500 MW phase moved to 2029, and the Kentucky PSC approved power for Justified. The author cites consensus targets in the $32–33 range against recent levels near $11–13 and references notes from TD Cowen, Wells Fargo and UBS. Treat the framing as a promotional post.
Rocket Lab down on the Neutron delay, with targets split
Rocket Lab is down 6.6% and this is the most heavily covered name on your list. On October 14 CEO Peter Beck said Neutron's first flight slips to 2027. An inspection found air pockets, or voids, in the forward dome of the first-stage carbon-composite propellant tank, traced to a recent design change that thickened sections for strength and made them harder to cure without trapping air. Beck said the bubbles wouldn't necessarily cause a failure but the tank missed internal safety margins: "Possible success isn't our standard." The manufacturing process has been fixed and validated on a second tank section, and the affected part is being rebuilt. The minimum hit is four months of qualification test and assembly; if key tests pass as early as January, a new date gets set, not before Q2 2027. Beck also said second and third rockets are already in production with upgrades pulled forward. Analysts split on magnitude, not direction: Needham held Buy and $120 while cutting its FY2027 revenue estimate on fewer Neutron flights; Citizens cut to $90 from $130, keeping Market Outperform, with Trevor Walsh noting the stock is down about 21% year-to-date against the aerospace and defence ETF down 7.6% and the Russell 3000 up 12%; KeyBanc cut to $100 from $135, Overweight; Stifel reiterated Buy at $132; Cantor Fitzgerald held Overweight at $122, with Andres Sheppard modelling a Q2 2027 debut and the first revenue-generating launch in Q4 2027. GuruFocus has the stock at $55.25 against a GF Value of $39.14, a GF Score of 77 with growth 10 of 10 and profitability 3 of 10, revenue up 53% year over year, and insider selling of $683.3m over twelve months with no buys. One headline-only item flags notable Thursday option activity in RKLB alongside OLLI and MCD.
Intuit, AST SpaceMobile and Nurix valuation notes
Intuit rose 6.4% to $330.17, but it is down 49.5% year-to-date and 48.7% over twelve months. GuruFocus puts GF Value at $831.99, a GF Score of 82 with profitability and growth both 10 of 10 and valuation and momentum both 2 of 10, a trailing P/E of 20.0x against a five-year median of 58.5x, and forward P/E of 13.9x. Insiders sold a net $357.2m over the past year. AST SpaceMobile is up 5.5% to $44.46 against a 52-week range of $39.87 to $133.86; GuruFocus shows a GF Score of just 44, growth 0 of 10 and profitability 1 of 10, with net insider selling of $450.8m. No company news behind either move in what I have. Nurix is up 5.4%: HC Wainwright kept Buy and raised its target to $36 from $34, with GuruFocus noting GF Value of $54.06 against $24.95 and a GF Score of 65. Separately, CSO Gwenn Hansen sold 1,452 shares at $25.00, total $36,300, under a 10b5-1 plan, having exercised options at $1.86; she still directly owns 117,227 shares. That article also recaps post-Q3 target moves from Stifel to $41 on the Roche collaboration, Morgan Stanley to $38, RBC to $35 and Truist to $33.
Adobe and the Nvidia expansion
Adobe is up 4.6% across several headline-only items saying it expanded its Nvidia partnership to speed up creative tools and agentic creation, with Brand Concierge using Nvidia Nemotron due for enterprise customers later this year. A separate GuruFocus headline asks whether it's too late after the rally, saying GF Value reads undervalued. Accenture is also up 4.6% on a GuruFocus valuation headline citing GF Value of $349.90 against $224.92.
Netflix content chief change
Netflix is up 2.9% with a dense headline-only cluster: Peter Rice, formerly of Disney, named chief content officer as Bajaria departs, alongside reported layoffs. Several of those headlines describe shares dipping or sliding, which sits against today's quoted gain. Rosenblatt stayed Neutral, BMO cut its target citing engagement concerns, and Jefferies assumed coverage with Buy at $85. Another headline notes heavy options activity ahead of earnings.
SpaceX headlines, stock lower
SPCX is down 2.3% despite the heaviest headline flow of any name. Tesla unveiled a redesigned Roadster at a SpaceX facility with SpaceX thrusters and a claimed 0.81-second 0-60. Evercore ISI raised its SPCX target to $275 on compute growth. On the geopolitics, Reuters reported the White House ordered SpaceX to limit Ukraine satellite service, a US official later clarified there are no Trump restrictions on Starshield for Ukraine, and Zelenskiy said there's no discussion of substituting Starlink; European satellite stocks extended a rally on the Starlink curb story. The EU plans to fast-track antitrust approval of a SpaceX rival. Musk also posted about a Star Mind computer co-engineered with Nvidia reaching volume production next year. All headline-only.
Semis, Micron insider filings and TSMC
Micron is up 1.9% on a very large batch of Form 4s dated 13 and 14 October covering CEO Sanjay Mehrotra, CFO Mark Murphy, COO Manish Bhatia and most of the board, plus chief legal officer Michael Ray selling $5.8m of stock. These are headline-only filings, so I can't say what's routine vesting versus discretionary. TSMC is down 1.8% after reporting a record quarter, with headlines describing a sell-off anyway and the CEO saying the gap between demand and supply remains large. Taiwan is reported to be planning a $4bn Texas hub for Nvidia's AI supply chain. Broadcom is down 0.6% on ETF-flow and chart headlines, plus a note that Anthropic secured a BB+ rating from KBRA ahead of a $35bn chip financing deal with another $60bn reportedly being assembled.
Everything else is quiet
The rest is low-signal: Take-Two up 4.0% on GTA VI optimism headlines and a Form 144, UiPath up 5.0% and Red Cat, Beam, Planet Labs and Nebius each with only a Form 144, Comcast up 3.4% and NetApp down 3.4% on GuruFocus valuation screens, TD Synnex down 3.3% with chair Dennis Polk selling $629k, AngloGold up 3.1%, Oracle up 3.0% on ETF buying and valuation headlines, Paychex up 2.2% declaring a $1.19 quarterly dividend, CRISPR up 2.6% with UBS initiating at Neutral and a $52 target, and a long tail of Apple ETF-flow items around the $5trn market cap with Apple itself down 0.3%. Datadog is down 1.1% even as Mizuho raised its target to $330. Nothing there needs a closer look on today's tape.
TradingView
Trading 212
